Cargando…
Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19
BACKGROUND: Since December 2019 coronavirus disease 2019 (COVID-19) outbreaks have occurred in China and many countries around the world. The effectiveness of oseltamivir on COVID-19 suspected outpatients without hypoxia was evaluated. METHODS: A total of 16 COVID-19 suspected medical personnel and...
Autor principal: | Chiba, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724617/ https://www.ncbi.nlm.nih.gov/pubmed/33296027 http://dx.doi.org/10.1007/s00508-020-01780-0 |
Ejemplares similares
-
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study
por: Shokri, Fazlollah, et al.
Publicado: (2023) -
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study
por: Shokri, Fazlollah, et al.
Publicado: (2023) -
Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017) -
Exertional hypoxia in patients without resting hypoxia is an early predictor of moderate to severe COVID-19
por: Bhasin, Ajay, et al.
Publicado: (2021) -
Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza: A Systematic Review and Meta-analysis
por: Hanula, Ryan, et al.
Publicado: (2023)